tiprankstipranks
Intensity Therapeutics, Inc. (INTS)
NASDAQ:INTS
US Market
INTS
Intensity Therapeutics, Inc.
RESEARCH TOOLSreports
Want to see INTS full AI Analyst Report?

Intensity Therapeutics, Inc. (INTS) Stock News & Sentiment

249 Followers
Intensity Therapeutics Stockholders Approve Proposals at Annual Meeting
Premium
Company Announcements
Intensity Therapeutics Stockholders Approve Proposals at Annual Meeting
20d ago
8K
INTS
U.S. Tariff and Trade Policy Risks Threaten Intensity Therapeutics’ Supply Chain, Costs, and Stock Valuation
Premium
Company Announcements
U.S. Tariff and Trade Policy Risks Threaten Intensity Therapeutics’ Supply Chain, Costs, and Stock Valuation
3M ago
INTS
Intensity Therapeutics Expands ATM Equity Offering Capacity
Premium
Company Announcements
Intensity Therapeutics Expands ATM Equity Offering Capacity
4M ago
8K
INTS
Intensity Therapeutics, Inc. (INTS) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Intensity Therapeutics, Inc. (INTS) Q4 Earnings Cheat Sheet
4M ago
INTS
Intensity Therapeutics Regains Nasdaq Compliance, Stabilizing Market Listing
Premium
Company Announcements
Intensity Therapeutics Regains Nasdaq Compliance, Stabilizing Market Listing
4M ago
8K
INTS
Upcoming Stock Splits This Week (February 17 to February 20) – Stay Invested
Premium
Market News
Upcoming Stock Splits This Week (February 17 to February 20) – Stay Invested
5M ago
SMX
WTO
Intensity Therapeutics Announces 1-for-25 Reverse Stock Split
Premium
Company Announcements
Intensity Therapeutics Announces 1-for-25 Reverse Stock Split
5M ago
8K
INTS
More INTS News >

INTS News on the Web

Intensity Therapeutics Stockholders Approve Proposals at Annual Meeting
TipRanks News
Neutral
Intensity Therapeutics Wins 2026 Award for Cancer Treatment Innovation—What Does This Mean for Patients and Investors?
Market Chameleon
Neutral
Intensity Therapeutics, Inc. (INTS) Receives a Buy from Alliance Global Partners
TipRanks News
Neutral
Intensity Therapeutics reports Q1 EPS (96c), consensus ($1.09)
TipRanks News
Bullish
Intensity Therapeutics upgraded to Buy from Hold at Freedom Broker
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Intensity Therapeutics, Inc. (INTS), IQVIA Holdings (IQV) and Xenon (XENE)
TipRanks News
Neutral
U.S. Tariff and Trade Policy Risks Threaten Intensity Therapeutics’ Supply Chain, Costs, and Stock Valuation
TipRanks News
Bearish
Intensity Therapeutics issued new patent in the US
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0.25 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is INTS’s Media Buzz Sentiment?
Currently, no data Available
What is INTS’s weekly average amount of articles?
In an average week, 0.25 articles about INTS are published.
    What is INTS’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    SEERSeer
    ARCTArcturus Therapeutics
    OFIXOrthofix Medical
    MOLNMolecular Partners
    CRNXCrinetics Pharmaceuticals
    Showing the stocks with the most bullish news sentiment over the past week